Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Condo Nordic Holding AB | CONDO | Nov 25, 2024 | 1.27 | -15.33 |
Consensus B | CAMB | Nov 25, 2024 | 11.95 | +0.84 |
Coor Service Management Holding | COOR | Nov 25, 2024 | 33.34 | +1.15 |
Corem Property Group A | COREA | Nov 25, 2024 | 6.92 | +2.37 |
Corem Property Group B | COREB | Nov 25, 2024 | 6.79 | +0.44 |
Corem Property Group D | CORED | Nov 25, 2024 | 247.50 | +0.41 |
Corem Property Group Pref | COREPREF | Nov 25, 2024 | 263.50 | +0.57 |
Corline Biomedical | CLBIO | Nov 25, 2024 | 6.26 | -2.49 |
Cortus Energy | CE | Nov 25, 2024 | 0.16 | -0.62 |
Creades A | CREDA | Nov 25, 2024 | 71.65 | +1.92 |
Creturner Group | CRET | Nov 25, 2024 | 0.14 | -8.28 |
Crown Energy | CRWN | Nov 25, 2024 | 0.58 | 0.00 |
Crunchfish | CFISH | Nov 25, 2024 | 1.32 | +2.64 |
CTEK | CTEK | Nov 25, 2024 | 16.36 | +0.49 |
CTT Systems | CTT | Nov 25, 2024 | 255.00 | +1.19 |
Curasight | CURAS | Nov 25, 2024 | 11.00 | +0.92 |
Cyber Security 1 | CYB1 | Nov 25, 2024 | 0.01 | 0.00 |
Cyclezyme AB | CYCLE | Nov 25, 2024 | 6.00 | -16.08 |
Cyxone | CYXO | Nov 25, 2024 | 0.03 | +14.29 |
Dala Energi | DE | Nov 25, 2024 | 100.00 | -0.50 |
Dedicare B | DEDI | Nov 25, 2024 | 60.70 | -2.10 |
Desenio | DSNO | Nov 25, 2024 | 0.29 | +0.70 |
Deversify Health | DEV | Nov 25, 2024 | 0.01 | 0.00 |
DevPort | DEVPB | Nov 25, 2024 | 27.70 | -0.72 |
Devyser Diagnostics | DVYSR | Nov 25, 2024 | 134.50 | +4.26 |
DexTech Medical | DEX | Nov 25, 2024 | 4.08 | 0.00 |
Diadrom Holding | DIAH | Nov 25, 2024 | 6.80 | -4.76 |
Diagonal Bio | DIABIO | Nov 25, 2024 | 0.03 | -3.85 |
Diamyd Medical B | DMYDB | Nov 25, 2024 | 12.92 | +2.54 |
Dignitana | DIGN | Nov 25, 2024 | 1.23 | +3.36 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.